Qiagen NV (QGEN)
44.99
-0.02
(-0.04%)
USD |
NYSE |
Dec 27, 16:00
45.01
+0.02
(+0.04%)
Pre-Market: 20:00
Qiagen Profit Margin (Quarterly): 19.54% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| LENZ Therapeutics Inc | -- |
| Oruka Therapeutics Inc | -- |
| Haemonetics Corp | 9.79% |
| Merus NV | -848.7% |
| uniQure NV | -1.94K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 2.58% |
| Return on Assets | 1.57% |
| Return on Invested Capital | 1.80% |
| Gross Profit Margin (Quarterly) | 61.43% |
| Operating Margin (Quarterly) | 24.08% |
| Return on Net Operating Assets | 2.10% |